Eur Rev Med Pharmacol Sci 2021; 25 (18): 5885-5886
DOI: 10.26355/eurrev_202109_26811

Comment on: LncRNA SNHG17 predicts poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma

B. Rinaldi, C. Giorgione, C. Silvestri, F. Masini, D. Macaro, M.V. Morone

Department of Experimental Medicine, Section of Pharmacology, University of Campania Luigi Vanvitelli, Naples, Italy. barbara.rinaldi@unicampania.it

 

Free PDF Download

To cite this article

B. Rinaldi, C. Giorgione, C. Silvestri, F. Masini, D. Macaro, M.V. Morone
Comment on: LncRNA SNHG17 predicts poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 18
Pages: 5885-5886
DOI: 10.26355/eurrev_202109_26811

Keywords Related articles:

  1. LncRNA SNHG17 predicts poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma
  2. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway
  3. Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis
  4. Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma
  5. LINC01296 promotes the proliferation and invasion by regulating microRNA-760 expression and predicts poor prognosis of hepatocellular carcinoma